COVINGTON VENTURE NEW GEN BIOTECH BAL V

 (MUTF_CA:CIG460)   Watch this mutual fund  
Find more results for Kelly Covington

Performance

Trailing returns

1 day
   
-3.82%  
1 week
   
-3.82%  
4 week
   
-1.02%  
3 month
   
-0.71%  
YTD   +0.72%
   
1 year
   
-24.17%  
3 years*
   
-0.17%  
5 years*
   
-2.24%  
*annualized
Best 3 month return+44.85%  
Worst 3 month return-16.44%  

Morningstar statistics

Morningstar category: Retail Venture Capital

Key statistics

Total assets5.55M 
Front load-  
Deferred load-  
Expense ratio-  
Management fee1.15%  
Fund familyCovington Group of Funds 

Asset allocation

Cash0.42%  
Stocks18.33%  
Bonds62.91%  
Preferred18.33%  
Other0.00%  

Purchase information

InitialCA$500  
AdditionalCA$50  
IRA InitialCA$500  
6.50-0.26(-3.82%)
Apr 11, 4:30PM EDT

Description

Creation of long-term capital appreciation driven by investments in select small to medium-sized Canadian enterprises. Investments are made only in businesses that are considered high-growth investment opportunities primarily inaccessible through the public market. These investments are primarily done via equity and convertible structures in order to maximize long-term potential. In addition, the investment objective of the Fund is to return investors' capital by paying to them an amount equal to the subscription price paid for the Class A shares on or about December 30th, 2011.
Asset managers:
Kelly Holman (Started: Mar 1, 2001)
Kent Plumley (Started: Mar 1, 2001)
Damian Lamb (Started: Mar 1, 2001)
Advisor Company:
Covington Capital Corporation
200 Front Street West, Suite 3003, PO Box 1
416 365 9822 (Fax)

Risk

  1 year 3 years 5 years 10 years  
Alpha* -24.04 3.34 2.22 -3.72
Beta* -0.06 -0.15 -0.12 -0.07
Mean annual return -2.00 0.36 0.06 -0.19
R-squared* 0.15 0.68 0.72 0.60
Standard deviation 17.71 27.37 22.45 16.84
Sharpe ratio -1.41 0.12 0.00 -0.25
* Against standard index

Top 10 holdings

Security Net Assets  
Toronto Dominion Bk 62.91%  
Disc. Dist. Biotech Cl A 18.33%  
Ottawa Biotechnology 18.33%